Natalya Igorevna Tapil’sKaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Natalya Igorevna Tapil’sKaya has a total of 336 co-authors. Here are the top co-authors by number of shared publications:
Тапильская Наталья Игоревна
Научно-исследовательский институт акушерства, гинекологии и репродуктологии им. Д.О. Отта
28 shared publications- Alexandr Mkrtichevich Gzgzyan
Saint Petersburg State University
21 shared publications - Evgeniia M. Komarova
Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
19 shared publications - Ksenia V. Ob’eDkova
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductive Medicine, 199034 St. Petersburg, Russia
17 shared publications - Igor Yurievich Kogan
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia
16 shared publications - Alevtina Mikhailovna Savicheva
Ott Research Institute of Obstetrics, Gynecology and Reproductology
13 shared publications
Latest Publications
- 22 October 2026
- Published by ECO-Vector LLC (Publications) in Urology Reports (St. - Petersburg)
- Vol. 16 (3) , 361-370
Evaluation of sperm DNA fragmentation, mitochondrial membrane potential, and oxidative stress as part of a comprehensive diagnostic workup for male infertility
BACKGROUND:Evaluation of conventional semen parameters generally does not allow the causes of impaired spermatogenesis to be determined; therefore, treatment of abnormal semen parameters remains empirical in most cases. The introduction into clinical practice of new methods to assess sperm mitochondrial function and oxidative stress will make it possible to stratify the etiologically heterogeneous group of patients with abnormal semen parameters and infertility, and to personalize treatment approaches. AIM:To assess the proportion of sperm with DNA fragmentation (SDF), high mitochondrial membrane potential, and high content of reactive oxygen species (ROS) in sperm in men from infertile couples. METHODS:The pilot prospective cross-sectional study included 20 men diagnosed with infertility in a couple. All patients underwent semen analysis, assessment of SDF by the TUNEL assay, assessment of SDF by the sperm chromatin structure assay (SCSA) with acridine orange staining, assessment of the proportion of sperm with high mitochondrial membrane potential, and assessment of the proportion of sperm with high ROS content. RESULTS:SDF measured by SCSA (SDF-SCSA) was significantly higher than SDF measured by TUNEL (SDF-TUNEL) (p 0.001). SDF-SCSA correlated positively with age (p= 0.02), the proportion of non-progressively motile sperm (p= 0.006), and the proportion of immotile sperm (p= 0.04), and correlated negatively with total sperm count (p= 0.02), the proportion of progressively motile sperm (p= 0.02), and total motile sperm count (p= 0.007). The proportion of sperm with high mitochondrial membrane potential correlated positively with body mass index (p= 0.03), sperm concentration (p= 0.006), and total sperm count (p= 0.02). Cluster analysis divided the total patient population into two cohorts characterized by different etiologies of the underlying spermatogenesis disorders—patients in cohorts 1 and 2 showed elevated SDF-TUNEL without an accompanying increase in the proportion of sperm with high ROS content, whereas patients in cohort 3 were characterized by an increase in the proportion of sperm with high ROS content, which was not accompanied by an increase in SDF. CONCLUSION:The results clearly demonstrate the need to assess additional ejaculate parameters, such as SDF, mitochondrial membrane potential, and ROS content in men from infertile couples, since the presence of normozoospermia does not allow fertile and infertile men to be differentiated, nor does it exclude the presence of disorders undetectable by routine semen microscopy. Stratifying the overall cohort of men with abnormal semen parameters into subgroups based on etiology enables personalized treatment and improves the effectiveness of couple infertility management.
- 22 October 2026
- Published by ECO-Vector LLC (Publications) in Urology Reports (St. - Petersburg)
- Vol. 16 (3) , 361-370
Evaluation of sperm DNA fragmentation, mitochondrial membrane potential, and oxidative stress as part of a comprehensive diagnostic workup for male infertility
BACKGROUND:Evaluation of conventional semen parameters generally does not allow the causes of impaired spermatogenesis to be determined; therefore, treatment of abnormal semen parameters remains empirical in most cases. The introduction into clinical practice of new methods to assess sperm mitochondrial function and oxidative stress will make it possible to stratify the etiologically heterogeneous group of patients with abnormal semen parameters and infertility, and to personalize treatment approaches. AIM:To assess the proportion of sperm with DNA fragmentation (SDF), high mitochondrial membrane potential, and high content of reactive oxygen species (ROS) in sperm in men from infertile couples. METHODS:The pilot prospective cross-sectional study included 20 men diagnosed with infertility in a couple. All patients underwent semen analysis, assessment of SDF by the TUNEL assay, assessment of SDF by the sperm chromatin structure assay (SCSA) with acridine orange staining, assessment of the proportion of sperm with high mitochondrial membrane potential, and assessment of the proportion of sperm with high ROS content. RESULTS:SDF measured by SCSA (SDF-SCSA) was significantly higher than SDF measured by TUNEL (SDF-TUNEL) (p 0.001). SDF-SCSA correlated positively with age (p= 0.02), the proportion of non-progressively motile sperm (p= 0.006), and the proportion of immotile sperm (p= 0.04), and correlated negatively with total sperm count (p= 0.02), the proportion of progressively motile sperm (p= 0.02), and total motile sperm count (p= 0.007). The proportion of sperm with high mitochondrial membrane potential correlated positively with body mass index (p= 0.03), sperm concentration (p= 0.006), and total sperm count (p= 0.02). Cluster analysis divided the total patient population into two cohorts characterized by different etiologies of the underlying spermatogenesis disorders—patients in cohorts 1 and 2 showed elevated SDF-TUNEL without an accompanying increase in the proportion of sperm with high ROS content, whereas patients in cohort 3 were characterized by an increase in the proportion of sperm with high ROS content, which was not accompanied by an increase in SDF. CONCLUSION:The results clearly demonstrate the need to assess additional ejaculate parameters, such as SDF, mitochondrial membrane potential, and ROS content in men from infertile couples, since the presence of normozoospermia does not allow fertile and infertile men to be differentiated, nor does it exclude the presence of disorders undetectable by routine semen microscopy. Stratifying the overall cohort of men with abnormal semen parameters into subgroups based on etiology enables personalized treatment and improves the effectiveness of couple infertility management.
- 16 September 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (4)
Efficacy of comprehensive treatment of patients with acute salpingo-oophoritis and exacerbation of chronic salpingo-oophoritis using a biological medicinal product based on the secretome of peripheral blood leukocytes
Recurrent inflammation of the uterine appendages is associated with an increased risk of chronic pelvic pain, tubal infertility, and fallopian tube damage. Therefore, there is a need for adjunctive therapies to standard antibacterial treatment that may help reduce persistent inflammatory activity. Objective. To evaluate the efficacy and safety of combination therapy including a biological medicinal product based on the peripheral blood leukocyte secretome (PBLS) in patients with acute salpingo-oophoritis and exacerbation of chronic salpingo-oophoritis. Material and methods. A total of 205 women aged 24—39 years with acute salpingo-oophoritis or exacerbation of chronic salpingo-oophoritis (ICD-10 codes: N70.0—N70.1) were enrolled. The main group received standard therapy in combination with PBLS, whereas the comparison group received standard therapy alone. Clinical and laboratory parameters were assessed on day 10, and recurrent exacerbations were recorded during 12 months of follow-up. Results. On day 10, complete pain resolution was achieved in 82.9% of patients in the main group and 71.0% in the comparison group (RR=1.167; 95% CI 1.002—1.359; p=0.044); mean VAS scores were 0.6±0.9 and 1.2±1.3, respectively (p20 mm/h (37.1% vs 51.0%; p=0.046), and C-reactive protein >5 mg/L (27.6% vs 41.0%; p=0.044) were less frequent in the main group. At 12 months, recurrent exacerbations were recorded in 0.9% of patients in the main group and 14.0% in the comparison group (p<0.001). No adverse events considered potentially related to PBLS were recorded. Conclusion. The addition of PBLS to standard therapy was associated with a higher rate of pain resolution, a lower frequency of persistent laboratory signs of systemic inflammation, and fewer recurrent exacerbations. These findings require confirmation in larger studies.
- 16 September 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (4)
Efficacy of comprehensive treatment of patients with acute salpingo-oophoritis and exacerbation of chronic salpingo-oophoritis using a biological medicinal product based on the secretome of peripheral blood leukocytes
Recurrent inflammation of the uterine appendages is associated with an increased risk of chronic pelvic pain, tubal infertility, and fallopian tube damage. Therefore, there is a need for adjunctive therapies to standard antibacterial treatment that may help reduce persistent inflammatory activity. Objective. To evaluate the efficacy and safety of combination therapy including a biological medicinal product based on the peripheral blood leukocyte secretome (PBLS) in patients with acute salpingo-oophoritis and exacerbation of chronic salpingo-oophoritis. Material and methods. A total of 205 women aged 24—39 years with acute salpingo-oophoritis or exacerbation of chronic salpingo-oophoritis (ICD-10 codes: N70.0—N70.1) were enrolled. The main group received standard therapy in combination with PBLS, whereas the comparison group received standard therapy alone. Clinical and laboratory parameters were assessed on day 10, and recurrent exacerbations were recorded during 12 months of follow-up. Results. On day 10, complete pain resolution was achieved in 82.9% of patients in the main group and 71.0% in the comparison group (RR=1.167; 95% CI 1.002—1.359; p=0.044); mean VAS scores were 0.6±0.9 and 1.2±1.3, respectively (p20 mm/h (37.1% vs 51.0%; p=0.046), and C-reactive protein >5 mg/L (27.6% vs 41.0%; p=0.044) were less frequent in the main group. At 12 months, recurrent exacerbations were recorded in 0.9% of patients in the main group and 14.0% in the comparison group (p<0.001). No adverse events considered potentially related to PBLS were recorded. Conclusion. The addition of PBLS to standard therapy was associated with a higher rate of pain resolution, a lower frequency of persistent laboratory signs of systemic inflammation, and fewer recurrent exacerbations. These findings require confirmation in larger studies.
- 16 September 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (4)
Endometriosis as a fibroinflammatory disease: enzyme therapy in comprehensive management. An Expert Council Resolution
This Resolution was prepared following the Expert Council meeting entitled «Endometriosis as a Fibro-Inflammatory Disease: The Role of Enzyme Therapy in the Comprehensive Management of Endometriosis-Associated Conditions,» held on June 3, 2026, at the V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation, as part of the XXIX International Congress «New Technologies in the Diagnosis and Treatment of Gynecological Diseases» with an International Course in Endoscopy. The document summarizes current evidence on the clinical heterogeneity of endometriosis, the mechanisms underlying inflammation, fibrogenesis, and postoperative adhesion formation, and addresses surgical and conservative treatment, chronic endometritis, endometriosis-associated infertility, and preparation for assisted reproductive technology programs. Following the discussion, the Expert Council noted the pathophysiological rationale for including bovhyaluronidase azoximer in the comprehensive treatment of endometriosis and associated conditions. Experimental and clinical evidence supports considering enzyme therapy as a promising adjunct to surgical and hormonal treatment targeting the inflammatory, fibrotic, and adhesive components of the disease. Potential areas of its application include postoperative management, pelvic adhesions, and concomitant chronic inflammatory diseases of the pelvic organs.
- 16 September 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (4)
Endometriosis as a fibroinflammatory disease: enzyme therapy in comprehensive management. An Expert Council Resolution
This Resolution was prepared following the Expert Council meeting entitled «Endometriosis as a Fibro-Inflammatory Disease: The Role of Enzyme Therapy in the Comprehensive Management of Endometriosis-Associated Conditions,» held on June 3, 2026, at the V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation, as part of the XXIX International Congress «New Technologies in the Diagnosis and Treatment of Gynecological Diseases» with an International Course in Endoscopy. The document summarizes current evidence on the clinical heterogeneity of endometriosis, the mechanisms underlying inflammation, fibrogenesis, and postoperative adhesion formation, and addresses surgical and conservative treatment, chronic endometritis, endometriosis-associated infertility, and preparation for assisted reproductive technology programs. Following the discussion, the Expert Council noted the pathophysiological rationale for including bovhyaluronidase azoximer in the comprehensive treatment of endometriosis and associated conditions. Experimental and clinical evidence supports considering enzyme therapy as a promising adjunct to surgical and hormonal treatment targeting the inflammatory, fibrotic, and adhesive components of the disease. Potential areas of its application include postoperative management, pelvic adhesions, and concomitant chronic inflammatory diseases of the pelvic organs.
- Open Access
- 3 August 2026
- Published by Endocrinology Research Centre in Bulletin of Reproductive Health
- Vol. 5 (2) , 27-39
Algorithm for prescribing hormonal contraception and menopausal hormone therapy in perimenopause
The present algorithm has been created and proposed for clinical using due to collaboration of Russian society of obstetricians and gynecologists, Russian Association Of Endocrinologists, International Association of Obstetricians-Gynecologists and Endocrinologists, National Association of Obstetricians-Gynecologists and Reproductologists "Women’s Health", Interdisciplinary Association of Healthy Aging Specialists, Interdisciplinary Association of Reproductive Medicine Specialists "MARS", Society of Obstetricians and Gynecologists of St. Petersburg and the North-Western Region and Interdisciplinary Association of Specialists in Anti-Aging Medicine.
- 3 August 2026
- Published by Endocrinology Research Centre in Bulletin of Reproductive Health
- Vol. 5 (2) , 27-39
Open AccessAlgorithm for prescribing hormonal contraception and menopausal hormone therapy in perimenopause
The present algorithm has been created and proposed for clinical using due to collaboration of Russian society of obstetricians and gynecologists, Russian Association Of Endocrinologists, International Association of Obstetricians-Gynecologists and Endocrinologists, National Association of Obstetricians-Gynecologists and Reproductologists "Women’s Health", Interdisciplinary Association of Healthy Aging Specialists, Interdisciplinary Association of Reproductive Medicine Specialists "MARS", Society of Obstetricians and Gynecologists of St. Petersburg and the North-Western Region and Interdisciplinary Association of Specialists in Anti-Aging Medicine.
- 25 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (6) , 94-104
Oxidative stress parameters in seminal plasma of men with high sperm DNA fragmentation
ABSRACT Introduction. In recent years, increasing attention has been paid to the issue of male reproductive health. The WHO guidelines state that the primary assessment of male fertility is reduced to a “basic semen examination” (concentration, morphology assessment, etc. of sperm). The study of DNA fragmentation, on the other hand, falls under the “expanded” list of tests. At the same time, a thorough evaluation of the antioxidant system’s activity and, in particular, the amount of oxidative modification products of macromolecules, is not included in this list. Sperm are sensitive cells to the effects of reactive oxygen species. Current research focuses on their condition and microenvironment, aimed at detecting the relationship between sperm quality and the development of oxidative stress. However, the question of whether to conduct an expanded and in-depth analysis in cases of normal sperm motility remains unresolved. Objective. The aim of this study was to evaluate the parameters of the antioxidant system and products of oxidative modifications of proteins and DNA of seminal plasma and spermatozoa at a normal level of their mobility and varying DNA fragmentation. Material and methods. This selective pilot single-center cross-sectional study included healthy men with different DNA fragmentation and normal sperm motility. We assessed the oxidative modifications of macromolecules (8-hydroxy-2’-deoxyguanosine; nitrotyrosine) and components of the antioxidant system (total antioxidant activity, catalase activity, superoxide dismutase activity, uric acid, and zinc ions) in seminal plasma and the cellular fraction of the ejaculate. Differences were considered significant at p15, a decrease in superoxide dismutase activity (p<0.010), zinc ion levels (p<0.050) and uric acid content (p<0.050) was observed, while an increase in nitrotyrosine content (p<0.050) was observed only in the cellular fraction of the ejaculate. Conclusions. The obtained data indicate that in men, despite normal sperm motility, a high degree of DNA fragmentation is associated with abnormal head morphology, highlighting the necessity of conducting an “expanded” semen examination. Changes in the components of the antioxidant system are found not within the cells themselves but in their microenvironment, which may likely lead to an increased formation of oxidative modification products of macromolecules in sperm. This is important to consider when collecting samples for ART protocols, as well as in relation to the overall quality and reproductive potential of sperm, which is crucial when planning for pregnancy.
- 25 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (6) , 94-104
Oxidative stress parameters in seminal plasma of men with high sperm DNA fragmentation
ABSRACT Introduction. In recent years, increasing attention has been paid to the issue of male reproductive health. The WHO guidelines state that the primary assessment of male fertility is reduced to a “basic semen examination” (concentration, morphology assessment, etc. of sperm). The study of DNA fragmentation, on the other hand, falls under the “expanded” list of tests. At the same time, a thorough evaluation of the antioxidant system’s activity and, in particular, the amount of oxidative modification products of macromolecules, is not included in this list. Sperm are sensitive cells to the effects of reactive oxygen species. Current research focuses on their condition and microenvironment, aimed at detecting the relationship between sperm quality and the development of oxidative stress. However, the question of whether to conduct an expanded and in-depth analysis in cases of normal sperm motility remains unresolved. Objective. The aim of this study was to evaluate the parameters of the antioxidant system and products of oxidative modifications of proteins and DNA of seminal plasma and spermatozoa at a normal level of their mobility and varying DNA fragmentation. Material and methods. This selective pilot single-center cross-sectional study included healthy men with different DNA fragmentation and normal sperm motility. We assessed the oxidative modifications of macromolecules (8-hydroxy-2’-deoxyguanosine; nitrotyrosine) and components of the antioxidant system (total antioxidant activity, catalase activity, superoxide dismutase activity, uric acid, and zinc ions) in seminal plasma and the cellular fraction of the ejaculate. Differences were considered significant at p15, a decrease in superoxide dismutase activity (p<0.010), zinc ion levels (p<0.050) and uric acid content (p<0.050) was observed, while an increase in nitrotyrosine content (p<0.050) was observed only in the cellular fraction of the ejaculate. Conclusions. The obtained data indicate that in men, despite normal sperm motility, a high degree of DNA fragmentation is associated with abnormal head morphology, highlighting the necessity of conducting an “expanded” semen examination. Changes in the components of the antioxidant system are found not within the cells themselves but in their microenvironment, which may likely lead to an increased formation of oxidative modification products of macromolecules in sperm. This is important to consider when collecting samples for ART protocols, as well as in relation to the overall quality and reproductive potential of sperm, which is crucial when planning for pregnancy.
- Open Access
- 8 December 2025
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 15 (5) , 933-943
Endometrial microbiota composition, α-defensin and transforming growth factor β1 levels in women with viral infection-driven infertility
A viral infection can interfere with implantation processes, affecting angiogenesis and endometrial receptivity, invasive trophoblast activity, and disrupting the balance of immune factors. The aim of the study was to assess endometrial microbiota composition, to measure the levels of α-defensin, growth factors in infertile women with viral infection. Materials and methods. 80 female infertile patients aged 26–46 years were examined divided into two groups: main group — women with endometrium-bearing viruses found in their (25 patients), and comparison group — 55 women without endometrium-bearing viruses. The endometrial microbiota was studied using molecular biological tests. α-Defensin (DEFa1), fibroblast growth factor 2 (FGF2), and transforming growth factor beta 1 (TGF-β1) in the endometrium were determined by ELISA. Results. Viruses were detected in endometrium 31.3% of the examined women. Herpesviridae viruses accounted for 34%, while Human Papillomavirus — 66%. Lactobacillus spp. most often dominated in endometrial microbiota in both groups (group 1–68% (17/25), group 2–78% (43/55)). The second most common microbial community types were Gardnerella vaginalis and Atopobium vaginae (Fannyhessea vaginae), which accounted for 20% and 15% in groups 1 and 2, respectively. In group 1, the highest viral load was found in endometrial samples with a high concentration of L. iners, as well as upon a decline or absence of Lactobacillus spp. (p 0.05). The concentration of L. crispatus and L. jensenii was significantly higher in group 2 (p 0.05). Patients with endometrium-bearing viruses had increased DEFα levels comprising 4.32 ng/ml (0.497; 16.1) compared with patients without endometrium-bearing viruses (0.7 ng/ml (0.7; 20)), as well as decreased levels of TGFb — 2 ng/ml (0.2; 9.8) and 4.54 ng/ml (0;16), respectively (p 0.05). Conclusions. Viral damage to the endometrium is associated with an increased concentration of L. iners, or with a deficiency or absence of Lactobacillus spp., as well as with an increased level of DEFα, active against viruses, and a decrease in TGF β1, indicating a violation of endometrial tissue homeostasis.
- 8 December 2025
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 15 (5) , 933-943
Open AccessEndometrial microbiota composition, α-defensin and transforming growth factor β1 levels in women with viral infection-driven infertility
A viral infection can interfere with implantation processes, affecting angiogenesis and endometrial receptivity, invasive trophoblast activity, and disrupting the balance of immune factors. The aim of the study was to assess endometrial microbiota composition, to measure the levels of α-defensin, growth factors in infertile women with viral infection. Materials and methods. 80 female infertile patients aged 26–46 years were examined divided into two groups: main group — women with endometrium-bearing viruses found in their (25 patients), and comparison group — 55 women without endometrium-bearing viruses. The endometrial microbiota was studied using molecular biological tests. α-Defensin (DEFa1), fibroblast growth factor 2 (FGF2), and transforming growth factor beta 1 (TGF-β1) in the endometrium were determined by ELISA. Results. Viruses were detected in endometrium 31.3% of the examined women. Herpesviridae viruses accounted for 34%, while Human Papillomavirus — 66%. Lactobacillus spp. most often dominated in endometrial microbiota in both groups (group 1–68% (17/25), group 2–78% (43/55)). The second most common microbial community types were Gardnerella vaginalis and Atopobium vaginae (Fannyhessea vaginae), which accounted for 20% and 15% in groups 1 and 2, respectively. In group 1, the highest viral load was found in endometrial samples with a high concentration of L. iners, as well as upon a decline or absence of Lactobacillus spp. (p 0.05). The concentration of L. crispatus and L. jensenii was significantly higher in group 2 (p 0.05). Patients with endometrium-bearing viruses had increased DEFα levels comprising 4.32 ng/ml (0.497; 16.1) compared with patients without endometrium-bearing viruses (0.7 ng/ml (0.7; 20)), as well as decreased levels of TGFb — 2 ng/ml (0.2; 9.8) and 4.54 ng/ml (0;16), respectively (p 0.05). Conclusions. Viral damage to the endometrium is associated with an increased concentration of L. iners, or with a deficiency or absence of Lactobacillus spp., as well as with an increased level of DEFα, active against viruses, and a decrease in TGF β1, indicating a violation of endometrial tissue homeostasis.
- Open Access
- 12 November 2025
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 19 (5) , 737-757
Myoinositol and D-chiroinositol in combination with folates and manganese as factors of male health: effect on sperm structure and fertility
An important factor of secondary male infertility is deficiency of vitamins and microelements. In the present work, a set of studies on myoinositol (MI), D-chiroinositol (DCI), their synergists (folates, manganese ions) in maintaining gametocyte structure and functioning has been systematized. MI and DCI improve the overall and progressive sperm motility by participating in signaling cascades downstream of reproductive hormone receptors (which normalizes androgen metabolism and helps prevent insulin resistance) and improving mitochondrial function. MI and DCI affect sperm maturation/functioning, motility and oocyte fertilization including those mediating inositol-dependent signaling protein phospholipase C-zeta (PLCz) and by modulating the electric fields of gametocytes. Clinical data on MI and DCI use in male infertility suggest an improved state of the zona pellucida, plasma membrane, cytoplasm and sperm reception. Manganese ions contribute to better gametocyte functioning by acting on testosterone concentration, increasing the activity of antioxidant enzymes and mitochondrial potential. Folates lowering gametotoxic homocysteine levels promote maintaining sperm DNA integrity. It is promising to prescribe MI/DCI in combination with organic manganese salts and folates to patients with idiopathic pathospermia, especially paralleled with carbohydrate metabolism disorders (insulin resistance) and reduced antioxidant protection.
- 12 November 2025
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 19 (5) , 737-757
Open AccessMyoinositol and D-chiroinositol in combination with folates and manganese as factors of male health: effect on sperm structure and fertility
An important factor of secondary male infertility is deficiency of vitamins and microelements. In the present work, a set of studies on myoinositol (MI), D-chiroinositol (DCI), their synergists (folates, manganese ions) in maintaining gametocyte structure and functioning has been systematized. MI and DCI improve the overall and progressive sperm motility by participating in signaling cascades downstream of reproductive hormone receptors (which normalizes androgen metabolism and helps prevent insulin resistance) and improving mitochondrial function. MI and DCI affect sperm maturation/functioning, motility and oocyte fertilization including those mediating inositol-dependent signaling protein phospholipase C-zeta (PLCz) and by modulating the electric fields of gametocytes. Clinical data on MI and DCI use in male infertility suggest an improved state of the zona pellucida, plasma membrane, cytoplasm and sperm reception. Manganese ions contribute to better gametocyte functioning by acting on testosterone concentration, increasing the activity of antioxidant enzymes and mitochondrial potential. Folates lowering gametotoxic homocysteine levels promote maintaining sperm DNA integrity. It is promising to prescribe MI/DCI in combination with organic manganese salts and folates to patients with idiopathic pathospermia, especially paralleled with carbohydrate metabolism disorders (insulin resistance) and reduced antioxidant protection.
- 16 October 2025
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 23 (3) , 295-301
Effect of granulocyte colony-stimulating factor on vascular endothelial growth factor expression in human endometrial cell culture
Background: A clinical observation of the results of treatment with recombinant granulocyte colony-stimulating factor (G-CSF) in patients with idiopathic neutropenia, a condition characterized by infertility and miscarriage, demonstrated spontaneous pregnancy in patients with a history of infertility. These results served as the basis for the use of G-CSF in refractory endometrial syndrome. Aim: The work aimed to investigate the effect of G-CSF on the expression of the vascular endothelial growth factor (VEGF) gene and the transcription factor HOXA10 in primary cultures of human endometrial cells. Methods: The study included eight female patients who were examined before enrolling in assisted reproductive technology programs. Endometrial aspiration biopsy was performed on days 5–10 of the menstrual cycle. The samples were cultured for 72 hours in DMEM supplemented with various concentrations of G-CSF (1 and 100 mg/mL). The expression of VEGF and HOXA10 genes was assessed using real-time polymerase chain reaction, and VEGF concentration in the culture medium was determined by enzyme-linked immunosorbent assay. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test. Results: A dose-dependent stimulatory effect of G-CSF on VEGF [F(2, 21) = 31.55; p 0.001] and HOXA10 [F(2, 21) = 14.31; p 0.001] gene expression was established. Upregulation was observed already at 1 mg/mL, whereas significant differences were achieved at 100 mg/mL. A significant increase in VEGF concentration in the culture medium was also detected in response to G-CSF [F(2, 21) = 109.4; p 0.001]. The stimulatory effect was observed in all examined endometrial samples. Conclusion: G-CSF exerts pleiotropic effects by stimulating VEGF and HOXA10 expression in endometrial cells in vitro. These mechanisms may underlie endometrial regeneration and improved receptivity, which are of particular relevance for treating patients with refractory endometrium and recurrent implantation failure in assisted reproductive technology programs
- 16 October 2025
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 23 (3) , 295-301
Effect of granulocyte colony-stimulating factor on vascular endothelial growth factor expression in human endometrial cell culture
Background: A clinical observation of the results of treatment with recombinant granulocyte colony-stimulating factor (G-CSF) in patients with idiopathic neutropenia, a condition characterized by infertility and miscarriage, demonstrated spontaneous pregnancy in patients with a history of infertility. These results served as the basis for the use of G-CSF in refractory endometrial syndrome. Aim: The work aimed to investigate the effect of G-CSF on the expression of the vascular endothelial growth factor (VEGF) gene and the transcription factor HOXA10 in primary cultures of human endometrial cells. Methods: The study included eight female patients who were examined before enrolling in assisted reproductive technology programs. Endometrial aspiration biopsy was performed on days 5–10 of the menstrual cycle. The samples were cultured for 72 hours in DMEM supplemented with various concentrations of G-CSF (1 and 100 mg/mL). The expression of VEGF and HOXA10 genes was assessed using real-time polymerase chain reaction, and VEGF concentration in the culture medium was determined by enzyme-linked immunosorbent assay. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test. Results: A dose-dependent stimulatory effect of G-CSF on VEGF [F(2, 21) = 31.55; p 0.001] and HOXA10 [F(2, 21) = 14.31; p 0.001] gene expression was established. Upregulation was observed already at 1 mg/mL, whereas significant differences were achieved at 100 mg/mL. A significant increase in VEGF concentration in the culture medium was also detected in response to G-CSF [F(2, 21) = 109.4; p 0.001]. The stimulatory effect was observed in all examined endometrial samples. Conclusion: G-CSF exerts pleiotropic effects by stimulating VEGF and HOXA10 expression in endometrial cells in vitro. These mechanisms may underlie endometrial regeneration and improved receptivity, which are of particular relevance for treating patients with refractory endometrium and recurrent implantation failure in assisted reproductive technology programs
- 27 August 2025
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 74 (4) , 45-54
Follicular fluid lipid profile assessment using MALDI mass spectrometry
BACKGROUND: Fatty acids are important components of the oocyte microenvironment, exhibiting both pro-inflammatory and lipotoxic effects as well as anti-inflammatory effects depending on the presence and quantity of unsaturated bonds. Changes in the lipid profile of follicular fluid in obese patients may be a mechanism that leads to a decrease in oocyte competence and pregnancy rate in assisted reproductive technology programs. However, the available literature data is fragmentary and contradictory, which dictates the need for further research. AIM: The aim of this study was to investigate the lipid profile of follicular fluid in patients undergoing assisted reproductive technology programs with ovarian stimulation depending on the body mass index using MALDI (matrix-assisted laser desorption/ionization) mass spectrometry. METHODS: This study involved patients undergoing infertility treatment using assisted reproductive technology in a short protocol using gonadotropin-releasing hormone antagonists. The levels of essential saturated and unsaturated fatty acids were analyzed in the follicular fluid of the first aspirated follicle using MALDI mass spectrometry. RESULTS: Two study groups were formed out of 138 patients: patients with normal body mass index (n = 38) and patients with overweight and obesity (n = 76). The latter were characterized by higher levels of myristic and stearic acids and lower levels of oleic acid in the follicular fluid. The level of myristic acid in the follicular fluid positively correlated with the body mass index, while the level of oleic acid negatively correlated with this parameter. CONCLUSION: The data obtained indicate that overweight and obesity are associated with increased levels of saturated myristic and stearic acids in the follicular fluid, which negatively impact folliculogenesis, as well as a decrease in the level of monounsaturated oleic acid in the follicular fluid, which is able to compensate for the lipotoxic effects of saturated fatty acids.
- 27 August 2025
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 74 (4) , 45-54
Follicular fluid lipid profile assessment using MALDI mass spectrometry
BACKGROUND: Fatty acids are important components of the oocyte microenvironment, exhibiting both pro-inflammatory and lipotoxic effects as well as anti-inflammatory effects depending on the presence and quantity of unsaturated bonds. Changes in the lipid profile of follicular fluid in obese patients may be a mechanism that leads to a decrease in oocyte competence and pregnancy rate in assisted reproductive technology programs. However, the available literature data is fragmentary and contradictory, which dictates the need for further research. AIM: The aim of this study was to investigate the lipid profile of follicular fluid in patients undergoing assisted reproductive technology programs with ovarian stimulation depending on the body mass index using MALDI (matrix-assisted laser desorption/ionization) mass spectrometry. METHODS: This study involved patients undergoing infertility treatment using assisted reproductive technology in a short protocol using gonadotropin-releasing hormone antagonists. The levels of essential saturated and unsaturated fatty acids were analyzed in the follicular fluid of the first aspirated follicle using MALDI mass spectrometry. RESULTS: Two study groups were formed out of 138 patients: patients with normal body mass index (n = 38) and patients with overweight and obesity (n = 76). The latter were characterized by higher levels of myristic and stearic acids and lower levels of oleic acid in the follicular fluid. The level of myristic acid in the follicular fluid positively correlated with the body mass index, while the level of oleic acid negatively correlated with this parameter. CONCLUSION: The data obtained indicate that overweight and obesity are associated with increased levels of saturated myristic and stearic acids in the follicular fluid, which negatively impact folliculogenesis, as well as a decrease in the level of monounsaturated oleic acid in the follicular fluid, which is able to compensate for the lipotoxic effects of saturated fatty acids.
- Open Access
- 13 August 2025
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (3) , 104-113
The Impact of Menopausal Hormone Therapy on Liver and Biliary Tract Health
Aim: to provide summarized data on the relationship between menopausal hormone therapy (MHT) and liver health.Key points. A decrease in estrogen production during the menopausal transition and a deficiency of estrogen and progesterone during postmenopause significantly affect lipid and carbohydrate metabolism and can lead to impaired liver function. With age, the risk of developing metabolic-associated fatty liver disease (MAFLD) in women increases significantly, due to a combination of hormonal changes, a higher incidence of metabolic disorders, and age-related factors. In turn, MAFLD is associated with an increased risk of cardiovascular disease, diabetes mellitus and metabolic disorders. In the absence of well-timed hormonal support, postmenopausal women are at high risk of developing serious complications, therefore, it is extremely important to select MHT with a favorable efficacy and safety profile. The approach to prescribing MHT should take into account the patient’s medical history, individual characteristics, as well as the mode of drug administration, considering the minimum effective dose.Conclusion. Oral combination MHT provides positive metabolic effects through the first-pass metabolism but is not associated with additional health risks.
- 13 August 2025
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (3) , 104-113
Open AccessThe Impact of Menopausal Hormone Therapy on Liver and Biliary Tract Health
Aim: to provide summarized data on the relationship between menopausal hormone therapy (MHT) and liver health.Key points. A decrease in estrogen production during the menopausal transition and a deficiency of estrogen and progesterone during postmenopause significantly affect lipid and carbohydrate metabolism and can lead to impaired liver function. With age, the risk of developing metabolic-associated fatty liver disease (MAFLD) in women increases significantly, due to a combination of hormonal changes, a higher incidence of metabolic disorders, and age-related factors. In turn, MAFLD is associated with an increased risk of cardiovascular disease, diabetes mellitus and metabolic disorders. In the absence of well-timed hormonal support, postmenopausal women are at high risk of developing serious complications, therefore, it is extremely important to select MHT with a favorable efficacy and safety profile. The approach to prescribing MHT should take into account the patient’s medical history, individual characteristics, as well as the mode of drug administration, considering the minimum effective dose.Conclusion. Oral combination MHT provides positive metabolic effects through the first-pass metabolism but is not associated with additional health risks.